- FILTERS Advanced
- Product Type
- Application
- Species / Reactivity
- Conjugation
- CE / IVD
- Supplier
-
- AAT Bioquest
- APExBIO
- Abeomics
- Adipogen Life Sciences
- Arbor Assays
- Aviva Systems Biology
- BPS Bioscience
- Beijing Wantai
- Bethyl Laboratories
- BioLegend
- Biocolor
- Bioline Reagents
- Bioss
- Cedarlane Laboratories
- Cell Biolabs
- Cell Technology
- Cusabio
- Diaclone
- Diagnostic BioSystems
- Epigentek
- Exalpha Biologicals
- Funakoshi
- GenHunter
- GeneTex
- Hycult biotechnology
- ImmunoChemistry Technologies
- LifeSpan Biosciences
- MBL
- MBL IVD
- MoBiTec
- Neuromics
- Nordic - MUbio
- Nordic BioSite
- Norgen Biotek
- OriGene
- PBL Assay
- ProSci
- Progen
- Proteintech
- Research Donors Ltd.
- SignalChem
- Sino Biological
- Streck
- US Biological
- ZYTOMED Systems
- Zeta Corporation
- Zymo Research
-
- EXCLUDE FILTERS
- Application
- Species / Reactivity
- Conjugation
| Name | Art no | Species Reactivity | Application | Conjugation | Range | Sensitivity | Size | Price |
|---|---|---|---|---|---|---|---|---|
|
4800
|
|
|
|
|
|
100 Assays
|
||
|
4805
|
|
|
|
|
|
100 Assays
|
||
|
4810
|
|
|
|
|
|
100 Assays
|
||
|
5331
|
|
ELISA
|
|
|
LOB: 1.41 pg/mL, LOQ: 13.66 pg/mL
|
96 Wells
|
||
|
5323
|
|
ELISA
|
|
|
|
96 Tests
|
||
|
5321
|
|
ELISA
|
|
|
|
96 Tests
|
||
|
5340
|
human
|
ELISA
|
|
0.78 to 50 ng/mL
|
LOB; 0.03 ng/mL, LOQ; 0.31 ng/mL
|
96 Wells
|
||
|
5333
|
|
ELISA
|
|
|
LOB: 0.051 ng/mL, LOD: 0.08 ng/mL
|
96 Wells
|
||
|
5310
|
|
ELISA
|
|
|
|
96 Tests
|
||
|
8450
|
|
|
|
|
|
30 Tests
|
||
|
RG-7874R
|
|
|
|
|
|
96 Wells
|
||
|
RG-7844R
|
|
ELISA
|
|
|
|
96 Wells
|
||
|
RG-7840R
|
|
ELISA
|
|
|
|
96 Wells
|
||
|
RG-7854R
|
|
ELISA
|
|
|
|
96 Wells
|
||
|
8485
|
|
|
|
|
|
Antibodies: 25 µl each. Positive control: 10 Tests
|
||
|
8486
|
|
|
|
|
|
1 kit
|
||
|
CY-8082
|
|
ELISA
|
|
Dilution factors need to be taken into consideration in calculating the units of 14to3to3 Gamma concentration. Results exceeding 14to3to3 Gamma level of 16,000 AU /mL should be repeated with diluted samples.
|
better than 250 AU/mL of sample.
|
96 Assays
|
||
|
CY-8151
|
|
|
|
|
|
96 Assays
|
||
|
CY-8098
|
|
ELISA
|
|
0.78 ng/mL to 50 ng/mL
|
better than 0.78 ng/mL of sample
|
96 Assays
|
||
|
CY-8066
|
|
ELISA
|
|
Results exceeding CMLtoadduct level of 20 ÎĽg/mL CMLtoHSA should be repeated with diluted samples. Dilution factors need to be taken into consideration in calculating the CMLtoHSA concentration.
|
better than 0.063 ÎĽg/mL of sample.
|
96 Assays
|
||
|
CY-8052
|
|
ELISA
|
|
|
better than 163.4 pg/ml of sample.
|
96 Assays
|
||
|
CY-8071
|
|
ELISA
|
|
Dilution factors need to be taken into consideration in calculating the Human CRP concentration.
Results exceeding Human CRP level of 9.5 ÎĽg/ml should be repeated with diluted samples.
|
better than 28.6 pg/mL of sample.
|
96 Assays
|
||
|
CY-8080
|
|
ELISA
|
|
Results exceeding free form human AIM/CD5L/Spα level of 5,000 ng/ml should be repeated with diluted samples. Dilution factors need to be taken into consideration in calculating the human AIM/CD5L/Spα concentration.
|
better than 0.745 ng/ml of sample.
|
96 Assays
|
||
|
CY-8050
|
|
ELISA
|
|
Dilution factors need to be taken into consideration in calculating the Adiponectin concentration. Results exceeding Adiponectin level of 32 ÎĽg/ml should be repeated with diluted samples.
|
better than 1.46 ng/ml of sample.
|
96 Assays
|
||
|
CY-8220
|
human
|
|
|
75 pg/mL ~ 4,800 pg/mL
|
71 pg/mL ~
|
96 Assays
|
||
|
CY-8119
|
|
|
|
|
|
96 Assay
|
||
|
CY-8103
|
human
|
|
|
|
|
96 Assay
|
||
|
CY-8115
|
human
|
|
|
62.5 - 4,000 pg/mL
|
18.9 pg/mL ~
|
96 Assays
|
||
|
CY-8107
|
human
|
|
|
|
|
96 Assays
|
||
|
CY-8074
|
human
|
ELISA
|
|
Dilution factors need to be taken into consideration in calculating the human chitotriosidase concentration. Results exceeding human chitotriosidase level of 3.6 ng/ml should be repeated with diluted samples.
|
better than 48.3 pg/ml of sample.
|
96 Assays
|
||
|
CY-8099
|
|
ELISA
|
|
62.5 pg/mL to 4,000 pg/mL
|
better than 40.0 pg/mL of sample.
|
96 Assays
|
||
|
CY-9050V2
|
|
ELISA
|
|
25 pg/mL to 1,600 pg/mL
|
better than 8.4 pg/mL of sample.
|
96 Assays
|
||
|
CY-8214
|
human
|
|
|
15 pg/mL ~ 960 pg/mL
|
6.2 pg/mL ~
|
96 Assays
|
||
|
CY-8122
|
human
|
ELISA
|
|
37.5 - 2,400 pg/mL
|
27.8 pg/mL -
|
96 Assay
|
||
|
CY-8116
|
human
|
|
|
400 - 6,400 pg/mL
|
228 pg/mL -
|
96 Assays
|
||
|
CY-8201
|
human
|
|
|
75 pg/m/l ~ 4,800 pg/mL
|
22.2 pg/mL ~
|
96 Assays
|
||
|
CY-8120
|
human
|
ELISA
|
|
1.5 - 96 ng/mL
|
0.626 ng/mL
|
96 Assay
|
||
|
CY-8085
|
|
ELISA
|
|
0.188 ng/mL to 12 ng/ml
|
better than 0.85 ng/ml of sample.
|
96 Assays
|
||
|
CY-8100
|
human
|
|
|
0.391 ng/mL to 25 ng/mL
|
better than 0.286 ng/mL of sample.
|
96 Assays
|
||
|
CY-8212
|
human
|
|
|
15 pg/mL ~ 960 pg/mL
|
9.2 pg/mL~
|
96 Assays
|
||
|
CY-8089
|
|
ELISA
|
|
0.31 ng/mL~20 ng/mL
|
259 pg/ml~
|
96 Assays
|
||
|
CY-8110
|
human
|
|
|
2 - 128 ng/mL
|
0.96 ng/mL ~
|
96 Assays
|
||
|
CY-8114
|
human
|
|
|
40 - 2,560 pg/mL
|
23 pg/mL ~
|
96 Assays
|
||
|
CY-8206
|
human
|
|
|
30 pg/mL ~ 1,920 pg/mL
|
5.8 pg/mL ~
|
96 Assays
|
||
|
CY-8207
|
human
|
|
|
30 pg/mL ~ 1,920 pg/mL
|
10.6 pg/mL ~
|
96 Assays
|
||
|
CY-8111
|
human
|
|
|
150 - 9,600 pg/mL
|
60 pg/mL -
|
96 Assays
|
||
|
CY-8079
|
|
ELISA
|
|
Results exceeding PCSK9 level of 1,000 ng/ml should be repeated with diluted samples. Dilution factors need to be taken into consideration in calculating the PCSK9 concentration.
|
better than 0.154 ng/ml of sample.
|
96 Assays
|
||
|
CY-8153
|
|
|
|
0.125 - 8 mAU/mL
|
0.042 mAU/mL -
|
96 Assays
|
||
|
CY-8117
|
human
|
|
|
0.4 ~ 25.6 ng/mL
|
0.156 ng/mL ~
|
96 Assays
|
||
|
CY-8101
|
human
|
|
|
|
better than 20.4 pg/mL of sample.
|
96 Assays
|
